Circulating monocytes are instead retained at the CD1a+ stage by GM-CSF, CXCL8, and CCL2 gradients in the primary tumor [34, 35], turning the pCRC into a functional “monocyte reservoir”. This evidence concerns the gene CCL2 and neoplasm.